Mitochondria are cellular structures best known for helping convert nutrients into usable energy. Because of this role, they have become a major focus of research involving metabolism, exercise, aging and several medical conditions.
Interest has also grown in therapies and supplements marketed as ways to “repair,” “recharge” or “regenerate” mitochondria. NAD+, methylene blue and berberine are among the most frequently discussed options.
Each affects biological pathways related to energy or metabolism. However, that does not mean they have been proven to reverse mitochondrial dysfunction, cure chronic disease or restore energy in every person.
Understanding what mitochondria do and what the available human evidence supports can help patients make informed decisions.
Mitochondria are found in most cells throughout the body. They are especially abundant in tissues with high energy demands, including the heart, brain and skeletal muscles.
One of their primary functions is helping produce adenosine triphosphate, or ATP. ATP provides energy for processes such as:
Mitochondria also participate in calcium regulation, cell signaling, oxidative balance and programmed cell death.
Their biology is complex. Mitochondria are not simply batteries that become empty and can be instantly recharged by a supplement.
Mitochondrial dysfunction generally means that mitochondria are not performing one or more of their normal functions effectively.
It may occur in inherited mitochondrial diseases caused by genetic variants. Changes in mitochondrial function are also observed in aging and many common health conditions.
However, finding mitochondrial changes in a disease does not necessarily mean mitochondrial dysfunction is its single root cause.
Conditions such as cardiovascular disease, diabetes, neurodegenerative disorders, inflammatory diseases and some metabolic conditions involve many interacting factors. These may include genetics, vascular health, immune activity, hormones, nutrition, environmental exposures and behavior.
Symptoms such as fatigue, brain fog, weakness and exercise intolerance are also nonspecific. They may result from:
These symptoms should be medically evaluated rather than automatically attributed to poor mitochondrial function.
The body maintains mitochondrial function through interconnected systems involving nutrition, oxygen delivery, movement, hormones, sleep and cardiovascular health.
Evidence-based habits that may support metabolic and cellular health include:
Physical activity is particularly important because exercise places an appropriate demand on muscles and can stimulate adaptations involving mitochondrial number and function.
No supplement can fully replace regular movement, adequate nutrition or treatment of an underlying medical condition.
Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme found in cells throughout the body.
It participates in reactions that help convert carbohydrates, fats and proteins into energy. NAD+ is also involved in cellular signaling, DNA-related processes and the activity of certain enzymes.
NAD+ continuously cycles between oxidized and reduced forms as it transfers electrons during cellular reactions.
Because NAD+ levels and metabolism may change with age and disease, researchers are studying whether influencing NAD+ pathways could have therapeutic applications. Much of the excitement comes from laboratory, animal and early human research rather than large clinical trials demonstrating improved health outcomes.
Some studies have observed lower NAD+ concentrations in certain tissues with advancing age. However, changes differ across tissues, study populations and measurement methods.
A lower measured level does not automatically establish that:
Researchers are still working to determine how NAD+ metabolism changes across the lifespan and whether altering it leads to meaningful improvements in human health. Reviews of clinical research describe NAD-targeted approaches as promising but still uncertain, with additional trials needed.
Intravenous NAD+ is marketed by some wellness providers for energy, mental clarity, recovery, addiction support and healthy aging.
Human research on direct NAD+ infusion remains limited. A small pilot study evaluated how intravenously administered NAD+ was metabolized, but it was not designed to prove that NAD+ improves fatigue, cognition, longevity or mitochondrial function.
More recent research has evaluated infusion tolerability and metabolic markers, but available studies remain too limited to establish broad clinical benefits for general wellness.
NAD+ therapy should not be represented as proven to:
Some people report subjective changes in energy or focus, but personal experiences cannot establish effectiveness.
Some supplements contain compounds the body can use in NAD+ metabolism, such as nicotinamide riboside or nicotinamide mononucleotide.
Studies suggest that certain precursors can raise NAD-related metabolites in blood. Whether this produces consistent improvements in physical function, cognition, metabolism or longevity is less clear.
The ability to change a laboratory marker does not necessarily prove that a therapy improves how a person feels or reduces disease risk.
Product quality, dose, absorption and individual metabolism may also affect results.
Methylene blue is a medication and chemical dye with a long history of medical and laboratory use.
The FDA-approved injectable methylene blue product is indicated for acquired methemoglobinemia, a condition in which hemoglobin cannot effectively deliver oxygen to tissues.
Methylene blue has also been studied for other medical uses and biological effects, including its interaction with cellular electron-transfer pathways. Laboratory and animal research has contributed to interest in its possible effects on mitochondria and the nervous system.
However, methylene blue is not FDA approved to improve:
A proposed cellular mechanism should not be treated as proof of clinical effectiveness.
In experimental settings, methylene blue can participate in electron-transfer reactions. This has led to claims that it acts as an alternative electron carrier or helps mitochondria bypass impaired components of the electron transport chain.
These mechanisms remain areas of scientific investigation.
It has not been established that wellness use of methylene blue reliably:
Results from cell cultures and animal models do not necessarily predict safe or effective treatment in humans.
Methylene blue is pharmacologically active and can cause significant interactions.
It inhibits monoamine oxidase A, an enzyme involved in breaking down certain neurotransmitters. Using methylene blue with serotonergic medications may cause serotonin syndrome, a potentially life-threatening reaction.
The FDA-approved prescribing information warns that serious or fatal serotonin syndrome can occur when methylene blue is used with serotonergic drugs.
Potentially interacting medications may include certain:
A complete medication and supplement review is essential before methylene blue is considered.
Possible signs of serotonin syndrome include:
These symptoms require prompt medical attention.
Methylene blue may also present concerns for people with glucose-6-phosphate dehydrogenase deficiency because of the risk of hemolytic anemia.
Other possible adverse effects or considerations include:
Medical-grade methylene blue should not be confused with industrial, aquarium or laboratory-grade products, which may contain contaminants and are not intended for human use.
Berberine is a plant-derived compound found in botanicals such as barberry, goldenseal and Oregon grape.
It has a long history of use in traditional medicine and is now sold as a dietary supplement. Researchers have studied its potential effects on:
Some studies suggest berberine may modestly affect certain metabolic markers. However, the National Center for Complementary and Integrative Health notes that studies vary in quality and that stronger research is needed to determine its benefits and safety.
Berberine is not a replacement for FDA-approved diabetes, cholesterol or weight-management medication.
Berberine is often described as activating adenosine monophosphate-activated protein kinase, or AMPK.
AMPK participates in cellular energy sensing and helps regulate processes involving glucose, fat metabolism and energy availability.
Calling AMPK the body’s “metabolic master switch” is an oversimplification. Human metabolism involves many interconnected enzymes, hormones and organs.
Research into a pathway does not establish that a supplement will:
Clinical outcomes matter more than changes observed in isolated cells or animal models.
Berberine can cause adverse effects and interact with medications.
Possible side effects include:
Berberine may affect enzymes and transport proteins involved in drug metabolism. This creates the potential for interactions with prescription medications.
Additional caution may be needed with:
Berberine is generally not recommended during pregnancy or breastfeeding because of potential risks to infants.
A healthcare provider or pharmacist should review all medications and supplements before use.
There is not enough high-quality clinical evidence to establish that combining NAD+, methylene blue and berberine produces a synergistic mitochondrial benefit.
Each substance has different:
Combining several biologically active therapies may also make it harder to determine which product caused a side effect or change in symptoms.
A combination should not be described as proven to regenerate mitochondria, correct chronic disease or produce predictable improvements in energy and cognition.
Medical appropriateness must be assessed individually.
Primary mitochondrial diseases are inherited disorders involving mitochondrial function. They can affect the brain, muscles, heart, liver, eyes and other organs.
These conditions require specialized medical assessment and may involve:
Treatment remains complex, and evidence for many proposed mitochondrial therapies is limited. Clinical reviews note that care is often individualized and that many commonly discussed interventions lack strong randomized controlled trial data.
Wellness treatments should not be presented as substitutes for specialist care.
Persistent fatigue can have many causes. A medical assessment may include a review of:
Diagnosing every case of fatigue as mitochondrial dysfunction may delay appropriate treatment.
Patients should seek medical evaluation for fatigue accompanied by:
Aerobic and resistance exercise can stimulate adaptations that help muscles use energy more efficiently.
A balanced program may include:
Exercise should be adapted to current health, ability and recovery needs.
Sleep supports glucose regulation, hormone signaling, appetite regulation and physical recovery.
Persistent insomnia, loud snoring, breathing pauses or excessive daytime sleepiness may indicate a sleep disorder that requires evaluation.
Cells need adequate energy, amino acids, vitamins and minerals to function.
An eating pattern that supports metabolic health may include:
Restrictive diets, extended fasting or inadequate calorie intake can worsen fatigue in some people.
Treating conditions such as diabetes, high blood pressure, thyroid disease, anemia, sleep apnea and cardiovascular disease can improve overall energy and function.
Chronic psychological stress may affect sleep, appetite, physical activity and perceived energy.
Helpful strategies may include:
Before beginning NAD+, methylene blue, berberine or another product marketed for cellular energy, ask:
A treatment plan should be based on a defined health need rather than a vague promise to optimize cells.
These categories are not interchangeable.
FDA-approved drugs undergo evaluation for safety, effectiveness, manufacturing quality, dosing and labeling for specific uses.
Methylene blue has an FDA-approved medical use, but that approval does not extend to general mitochondrial health or wellness.
Compounded medications are prepared for an individual patient based on a prescription. They are not FDA approved and are not reviewed by the FDA for safety, effectiveness or quality before being marketed.
A compounded product may be appropriate when a licensed provider identifies a clinical need that cannot be met by an available approved medication.
Dietary supplements do not undergo the same premarket approval process as prescription drugs. Their purity, potency and ingredient consistency may vary.
A supplement being described as “natural” does not mean it is risk-free.
Claims that mitochondrial therapies produce predictable monthly stages of recovery are not supported by strong clinical evidence.
There is no established timeline showing that patients should expect:
Symptom changes vary and may be influenced by sleep, nutrition, medications, underlying health conditions and expectations.
Treatment effectiveness should be evaluated using clinically meaningful measures rather than a predetermined wellness timeline.
Mitochondria are essential to energy metabolism, but mitochondrial health cannot be reduced to a single supplement, infusion or medication.
NAD+ is necessary for cellular energy reactions, yet evidence that NAD+ therapy reverses aging, chronic fatigue or mitochondrial dysfunction remains limited. Methylene blue has established medical uses and scientifically interesting cellular effects, but it is not approved for general energy, cognition or longevity and can cause serious drug interactions. Berberine may affect metabolic markers, but it has not been proven to regenerate mitochondria or replace prescribed treatment.
Regular physical activity, adequate sleep, balanced nutrition and management of underlying health conditions remain foundational to metabolic and cellular health.
TeleWellnessMD® connects patients with licensed healthcare providers who can review symptoms, medical history, medications and wellness goals before determining whether a particular therapy may be appropriate.
This content is for educational and informational purposes only and should not be interpreted as medical advice. TeleWellnessMD® is a technology platform that connects patients with licensed healthcare providers. TeleWellnessMD® does not practice medicine, provide medical advice, or dispense medications. All therapies require evaluation and approval by a licensed healthcare provider. Results may vary. Prescription required.